Work

Optimal management of EGFR -mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapy

Year: 2017

Type: review

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2017.05.009

Authors: Bin-Chi Liao, Chia-Chi Lin, Jih-Hsiang Lee, James Chih-Hsin Yang

Institutions: National Taiwan University, National Taiwan University Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Genentech

OpenAlex ID: W2613582623

FWCI: 1.396

Cites: 91

Cited by: 47

Related to: 10